Biomira Inc, Immunex deal

BIOMF and IMNX agreed to co-promote BIOMF's Truquant BR, a diagnostic for the detection of recurrent Stage II and III breast cancer. The product, manufactured by BIOMF's Biomira Diagnostics subsidiary, received an approvable letter from the FDA in September, and is expected to be approved in the first quarter of 1996. ...